FAGR.BR
Fagron N.V.
1W: -3.4%
1M: -3.2%
3M: +3.4%
YTD: -2.5%
1Y: +7.7%
3Y: +44.7%
5Y: +12.8%
€21.40 ($24.75)
-0.10 (-0.47%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap€1.6B ($1.8B)
52W Range17.54-23.85
Volume92,492
Avg Volume100,588
Beta0.31
Dividend€0.35
Analyst Ratings
No analyst coverage
Company Info
CEORafael Padilla
Employees3,828
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2007-10-05
Websitefagron.com
Venecoweg 20A
Nazareth 9810
BE
Nazareth 9810
BE
32 8 001 28 80
About Fagron N.V.
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
Latest News
No recent news
Recent Insider Trades
No insider trades found